Vibegron (RVT-901/MK-4618/KRP-114V) Administered Once Daily as Monotherapy or Concomitantly with Tolterodine in Patients with an Overactive Bladder: A Multicenter, Phase IIb, Randomized, Double-blind, Controlled Trial

Published 2018 View Full Article

Authors

Keywords

β3-Adrenergic receptor agonist, Dry mouth, Micturitions, Overactive bladder, Tolterodine, Urge incontinence, Urinary frequency, Urinary urgency, Vibegron

Journal

EUROPEAN UROLOGY

Volume 75, Issue 2, Pages 274-282

Publisher

Elsevier BV

Online

2018-10-25

DOI

10.1016/j.eururo.2018.10.006

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now